Old Web
English
Sign In
Acemap
>
Paper
>
CD38 x ICAM1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
CD38 x ICAM1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
2021
Xiaocheng Chen
Oi Kwan Wong
Leonard Post
Keywords:
Cancer research
Multiple myeloma
bispecific antibody
Lymphoma
Medicine
CD38
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]